MPGOX
Price
$8.81
Change
-$0.00 (-0.00%)
Updated
Jun 20 closing price
Net Assets
105.97M
MSNCX
Price
$10.46
Change
-$0.00 (-0.00%)
Updated
Jun 20 closing price
Net Assets
460.15M
Interact to see
Advertisement

MPGOX vs MSNCX

Header iconMPGOX vs MSNCX Comparison
Open Charts MPGOX vs MSNCXBanner chart's image
MFS GA Municipal Bond R6
Price$8.81
Change-$0.00 (-0.00%)
VolumeN/A
Net Assets105.97M
MFS NC Municipal Bond A
Price$10.46
Change-$0.00 (-0.00%)
VolumeN/A
Net Assets460.15M
MPGOX vs MSNCX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
MPGOX vs. MSNCX commentary
Jun 24, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MPGOX is a Hold and MSNCX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
MSNCX has more cash in the bank: 460M vs. MPGOX (106M). MPGOX (3.39) and MSNCX (3.27) have matching dividends . MPGOX was incepted earlier than MSNCX: MPGOX (8 years) vs MSNCX (41 years). MSNCX (0.86) is less costly to investors than MPGOX (0.68). MPGOX (20.00) and MSNCX (20.00) have comparable annual turnover. MPGOX has a lower initial minimum investment than MSNCX: MPGOX (0) vs MSNCX (1000). MPGOX annual gain was more profitable for investors over the last year : -0.50 vs. MSNCX (-0.59). MPGOX return over 5 years is better than : 1.97 vs. MSNCX (1.71).
MPGOXMSNCXMPGOX / MSNCX
Total Expense Ratio0.600.8471%
Annual Report Gross Expense Ratio0.680.8679%
Fund Existence8 years41 years-
Gain YTD-2.022-2.020100%
Front LoadN/A4%-
Min. Initial Investment01000-
Min. Initial Investment IRAN/AN/A-
Net Assets106M460M23%
Annual Yield % from dividends3.393.27104%
Returns for 1 year-0.50-0.5985%
Returns for 3 years7.776.99111%
Returns for 5 years1.971.71115%
Returns for 10 yearsN/A12.11-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
VGIFX85.110.10
+0.12%
JPMorgan US Value R5
SCAVX13.65N/A
N/A
AB Small Cap Value A
MVISX43.19N/A
N/A
Patient Opportunity IS
FISGX39.46-0.12
-0.30%
Nuveen Small/Mid Cap Growth Opp I
RYWVX69.86-1.66
-2.32%
Rydex Emerging Markets 2X Strategy H